Chromatin organisation and human disease

Bibliography

• VERREAULT A: De novo nucleosome assembly: new pieces in an old puzzle. GenesDev. (2000) 1 4 :1430–1438.
   Google Scholar
• KIKYO N, WOLFFE AP: Repr ogramming nuclei: insights from cloning, nuclear transfer and heterokaryons. Cell ScL (2000) 113:11–20.
   PubMedGoogle Scholar
• ZARET KS, YAMAMOTO KR: Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell (1984) 38:29–38.
   PubMed Web of Science ®Google Scholar
• •First study to report dynamic alterations in chromatin structure concomitant with changes in expression levels of a particular gene. See also [99, 100].
   Google Scholar
• LAU OD, KUNDU TK, SOCCIO RE et al.: HATs off: selective synthetic inhibitors of the histone acetyl-transferases p300 and PCAF. Mol. Cell. (2000) 5:589–595.
   PubMed Web of Science ®Google Scholar
• YOSHIDA M, KIJIMA M, AKITA M, BEPPU T: Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.J. Biol. Chem. (1990) 265:17174–17179.
   Google Scholar
• YOSHIDA M, HORINOUCHI S, BEPPU T: Trichostatin Aand trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays (1995) 17:423–430.
   PubMed Web of Science ®Google Scholar
• RICHON VM, EMILIANI S, VERDIN E et al.: A class of hybrid polar inducers of transformed cell differentia-tion inhibits histone deacetylases. Proc. Natl. Acad. ScL USA (1998) 95:3003–3007.
   PubMed Web of Science ®Google Scholar
• WOLFFE AP: Chromatin Structure and Function (3rd Ed). Academic Press, San Diego, CA, USA (1998).
   Google Scholar
• PATTERTON HG, SIMPSON RT: Nucleosomal location of the STE6 TATA box and Mat alpha 2p-mediated repres-sion. Mol Cell. Biol (1994) 14:4002–4010.
   PubMedGoogle Scholar
• LI Q, WRANGE O: Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol. Cell. Biol. (19 9 5) 15:4375-4384.
   Google Scholar
• BLOMQUIST P, LI Q, WRANGE O: The affinity of nuclearfactor 1 for its DNA site is drastically reduced by nucleosome organization irrespective of its rotational or translational position. J. Biol. Chem. (1996) 271:153–159.
   PubMedGoogle Scholar
• HAN M, GRUNSTEIN M: Nucleosome loss activates yeastdownstream promoters in vivo. Cell (1988) 55:1137–1145.
   PubMed Web of Science ®Google Scholar
• TAYLOR IC, WORKMAN JL, SCHUETZ TJ, KINGSTON RE:Facilitated binding of GALA and heat shock factor to nucleosomal templates: differential function of DNA-binding domains. Genes Dev. (1991) 5:1285–1298.
   PubMedGoogle Scholar
• WYRICK JJ, HOLSTEGE FC, JENNINGS EG et al.: Chromo-somal landscape of nucleosome-dependent gene expression and silencing in yeast. Nature (1999) 402:418–421.
   PubMed Web of Science ®Google Scholar
• •Genome-wide expression profiling used to look at the role of chromatin in regulating mRNA levels. Also see [78].
   Google Scholar
• LI Q, WRANGE O: Translational positioning of a nucleo-somal glucocorticoid response element modulates glucocorticoid receptor affinity. Genes Dev. (1993) 7:2471–2482.
   PubMedGoogle Scholar
• WONG J, LI Q, LEVI BZ, SHI YB, WOLFFE AP: Structural and functional features of a specific nucleosome containing a recognition element for the thyroid hormone receptor. EMBO. J (1997) 16:7130–7145.
   PubMedGoogle Scholar
• NG HH, BIRD A: Flistone deacetylases: silencers for hire. Trends Biochem. ScL (2000) 25:121–126.
   PubMed Web of Science ®Google Scholar
• CHEUNG WL, BRIGGS SD, ALLIS CD: Acetylation and chromosomal functions. CUIT. Opin. Cell Biol. (2000) 12:326–333.
   PubMed Web of Science ®Google Scholar
• PETERSON CL, WORKMAN JL: Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. (2000) 10:187–192.
   PubMed Web of Science ®Google Scholar
• ALLFREY V, FAULKNER RM, MIRSKY AE: Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. ScL USA (1964) 51:786–794.
   PubMed Web of Science ®Google Scholar
• •The discovery of histone tail acetylation.
   Google Scholar
• BROWNELL JE, ZHOU J, RANALLI T et al.: Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell (1996) 84:843–851.
   PubMed Web of Science ®Google Scholar
• TAUNTON J, HASSIG CA, SCHREIBER SL: A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science (1996) 272:408–411.
   PubMed Web of Science ®Google Scholar
• STRUHL K: Flistone acetylation and transcriptional regulatory mechanisms. Genes Dev. (1998) 12:599–606.
   PubMed Web of Science ®Google Scholar
• GRUNSTEIN M: Histone acetylation in chromatin structure and transcription. Nature (1997) 389:349–352.
   PubMed Web of Science ®Google Scholar
• STRAHL BD, ALLIS CD: The language of covalent histone modifications. Nature (2000) 403:41–45.
   PubMed Web of Science ®Google Scholar
• SPENCER VA, DAVIE JR: Role of covalent modifications of histones in regulating gene expression. Gene (1999) 240:1–12.
   PubMedGoogle Scholar
• LUGER K, MADER AW, RICHMOND RK, SARGENT DF, RICHMOND TJ: Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature (1997) 389:251–260.
   PubMed Web of Science ®Google Scholar
• •High-resolution crystal structure of the nucleosome.
   Google Scholar
• WOLFFE AP, HAYES JJ: Chromatin disruption and modification. Nucleic Acids Res. (1999) 27:711–720.
   PubMed Web of Science ®Google Scholar
• HANSEN JC, TSE C, WOLFFE AP: Structure and function of the core histone N-termini: more than meets the eye. Biochemistry (1998) 37:17637–17641.
   PubMed Web of Science ®Google Scholar
• AUSIO J, DONG F, VAN HOLDE KE: Use of selectivelytrypsinized nucleosome core particles to analyze the role of the histone 'tails' in the stabilization of the nucleosome. j Mol. Biol. (1989) 206:451–463.
   PubMed Web of Science ®Google Scholar
• HAYES JJ, CLARK DJ, WOLFFE AP: Ilistone contributionsto the structure of DNA in the nucleosome. Proc. Natl Acad. ScL USA (1991) 88:6829–6833.
   PubMed Web of Science ®Google Scholar
• SHIBAHARA K, VERREAULT A, STILLMAN B: The N-terminal domains of histones H3 and H4 are not necessary for chromatin assembly factor-1-mediated nucleosome assembly onto replicated DNA in vitro. Proc. Natl. Acad. ScL USA (2000) 97:7766–7771.
   PubMed Web of Science ®Google Scholar
• LING X, HARKNESS TA, SCHULTZ MC, FISHER-ADAMS G, GRUNSTEIN M: Yeast histone H3 and H4 amino termini are important for nucleosome assembly in vivo and in vitro: redundant and position-independent functions in assembly but not in gene regulation. Genes Dev. (1996) 10: 686–699.
   Google Scholar
• LENFANT F, MANN RK, THOMSEN B, LING X, GRUNSTEINM: All four core histone N-termini contain sequences required for the repression of basal transcription in yeast. EMBO. J (1996) 15:3974–3985.
   PubMedGoogle Scholar
• HUANG L, ZHANG W, ROTH SY: Amino termini of histones H3 and H4 are required for a1-alpha2 repres-sion in yeast. Mol. Cell. Biol. (1997) 17:6555–6562.
   PubMedGoogle Scholar
• ZHANG W, BONE JR, EDMONDSON DG, TURNER BM, ROTH SY: Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO. J (1998) 17:3155–3167.
   PubMed Web of Science ®Google Scholar
• ••Sophisticated genetic experiments in budding yeast providedefinitive evidence of a role for acetylation in transcriptional activation. Also see [41].
   Google Scholar
• TSE C, SERA T, WOLFFE AP, HANSEN JC: Disruption ofhigher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell. Biol. (1998) 18:4629–4638.
   PubMed Web of Science ®Google Scholar
• HEBBES TR, THORNE AW, CRANE-ROBINSON C: A directlink between core histone acetylation and transcrip-tionally active chromatin. EMBO. J. (1988) 7:1395–1402.
   PubMed Web of Science ®Google Scholar
• •Together with [39], strong evidence for a correlation between targeted chromosome modification/remodelling and transcriptional activation in metazoa.
   Google Scholar
• HEBBES TR, CLAYTON AL, THORNE AW, CRANE-ROBINSON C: Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken 13-globin chromosomal domain. EMBO. J. (1994) 13:1823–1830.
   PubMed Web of Science ®Google Scholar
• ANNUNZIATO AT, SEALE RL: Ilistone deacetylation isrequired for the maturation of newly replicated chromatin. j Biol. Chem. (1983) 258:12675–12684.
   PubMedGoogle Scholar
• WITTSCHIEBEN BO, FELLOWS J, DU W, STILLMAN DJ, SVEJSTRUP JQ: Overlapping roles for the histone acetyltransferase activities of SAGA and Hongator in vivo. EMBO. (2000) 19:3060–3068.
   PubMed Web of Science ®Google Scholar
• WADE PA, PRUSS D, WOLFFE AP: flistone acetylation: chromatin in action. Trends Biochem. Sci. (1997) 22:128–132.
   PubMed Web of Science ®Google Scholar
• KOUZARIDES T: flistone acetylases and deacetylases in cell pr olifer ation . Curr. Opin. Genet. Dev. (1999) 9:40–48.
   PubMed Web of Science ®Google Scholar
• STERNER DE, BERGER SL: Acetylation of histones and transcription-related factors. Mkt-obit)]. Mol Biol. Rev. (2000) 64:435–459.
   PubMed Web of Science ®Google Scholar
• •Excellent review on HATs that offers many helpful and comprehensive summaries and tables.
   Google Scholar
• WINSTON F, ALLIS CD: The bromodomain: a chromatin-targeting module? [news]. Nature Struct. Biol. (1999) 6:601–604.
   PubMedGoogle Scholar
• DHALLUIN C, CARLSON JE, ZENG L, HE C, AGGARWAL AK, ZHOU MM: Structure and ligand of a histone acetyl-transferase bromodomain. Nature (1999) 399:491–496.
   PubMed Web of Science ®Google Scholar
• DUTNALL RN, TAFROV ST, STERNGLANZ R, RAMAKRISHNAN V: Structure of the histone acetyl-transferase Had: a paradigm for the GCN5-related N-acetyltransferase superfamily. Ce//(1998) 94:427–438.
   Google Scholar
• LIN Y, FLETCHER CM, ZHOU J, ALLIS CD, WAGNER G: Solution structure of the catalytic domain of GCN5 histone acetyltransferase bound to coenzyme A. Nature (1999) 400:86–89.
   PubMedGoogle Scholar
• CLEMENTS A, ROJAS JR, TRIEVEL RC, WANG L, BERGER SL, MARMORSTEIN R: Crystal structure of the histone acetyltransferase domain of the human PCAF transcriptional regulator bound to coenzyme A. EMBO. J. (1999) 18:3521–3532.
   PubMed Web of Science ®Google Scholar
• TRIEVEL RC, ROJAS JR, STERNER DE et al: Crystal structure and mechanism of histone acetylation of the yeast GCN5 transcriptional coactivator [see comments]. Proc. Natl. Acad. Sci. USA (1 9 9 9) 96:8931-8936.
   Google Scholar
• XU W, EDMONDSON DG, ROTH SY: Mammalian GCN5and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates. Mol. Cell. Biol. (1998) 18:5659–5669.
   PubMedGoogle Scholar
• GRANT PA, EBERHARTER A, JOHN S, COOK RG, TURNER BM, WORKMAN JL: Expanded lysine acetylation specificity of Gcn5 in native complexes. J. Biol. Chem. (1999) 274:5895–5900.
   PubMed Web of Science ®Google Scholar
• SCHILTZ RL, MIZZEN CA, VASSILEV A, COOK RG, ALLIS CD, NAKATANI Y: Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. j Biol. Chem. (1999) 274:1189–1192.
   PubMed Web of Science ®Google Scholar
• XU L, GLASS CK, ROSENFELD MG: Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. (1999) 9:140–147.
   PubMed Web of Science ®Google Scholar
• ROBYR D, WOLFFE AP, WAHLI W: Nuclear hormone receptor coreg-ulators in action: diversity for shared tasks. Mol. Endocrinol (2000) 14:329–347.
   PubMedGoogle Scholar
• GRANT PA, DUGGAN L, COTE J et al.: Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev. (1997) 11:1640–1150.
   PubMed Web of Science ®Google Scholar
• CHEN H, LIN RJ, SCHILTZ RL et al.: Nuclear receptorcoactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 90:569–580.
   PubMed Web of Science ®Google Scholar
• BRAUNSTEIN M, ROSE AB, HOLMES SG, ALLIS CD, BROACH JR: Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. (1993) 7:592–604.
   PubMed Web of Science ®Google Scholar
• BRAUNSTEIN M, SOBEL RE, ALLIS CD, TURNER BM, BROACH JR: Efficient transcriptional silencing in Saccharomyces cerevisiae requires a heterochro-matin histone acetylation pattern. Mol. Cell. Biol. (1996) 16:4349–4356.
   PubMed Web of Science ®Google Scholar
• JEPPESEN P, TURNER BM: The inactive X chromosomein female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell (1993) 74:281–289.
   PubMed Web of Science ®Google Scholar
• BONE JR, LAVENDER J, RICHMAN R, PALMER MJ, TURNERBM, KURODA MI: Acetylated histone H4 on the male X chromosome is associated with dosage compensation in Drosophila. Genes Dev. (1994) 8:96–104.
   PubMedGoogle Scholar
• COLLINGWOOD TN, URNOV FD, WOLFFE AP: Nuclearreceptors: coactivators, corepressors and chromatin remodeling in the control of transcription. j Mol Endocrinol. (1999) 23:255–275.
   PubMed Web of Science ®Google Scholar
• MAGNAGHI-JAULIN L, AIT-SI-ALI S, HAREL-BELLAN A:flistone acetylation and the control of the cell cycle. Prog. Cell Cycle Res. (2000) 4:41–47.
   PubMedGoogle Scholar
• MIZZEN CA, YANG XJ, KOKUBO T et al.: The TAF(II)250subunit of TFIID has histone acetyltransferase activity. Cell (1996) 87:1261–1270.
   PubMed Web of Science ®Google Scholar
• COLLINGWOOD TN, RAJANAYAGAM O, ADAMS M et al.: Anatural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc. Natl. Acad. ScL USA (1997) 94:248–253.
   PubMedGoogle Scholar
• •Genetic evidence in human patients for the role of HAT targeting in transcriptional activator function. See also [66].
   Google Scholar
• COLLINGWOOD TN, WAGNER R, MATTHEWS CH et al: Arole for helix 3 of the TRI3 ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. EMBO. J. (1998) 17:4760–4770.
   PubMed Web of Science ®Google Scholar
• BUGGY JJ, SIDERIS ML, MAK P, LORIMER DD, MCINTOSHB, CLARK JM: Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem. j (2000) 350:199–205.
   PubMedGoogle Scholar
• KAO HY, DOWNES M, ORDENTLICH P, EVANS RM: Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. (2000) 14: 55–66.
   Google Scholar
• WADE PA, JONES PL, VERMAAK D, WOLFFE AP: A multiple subunit Mi-2 histone deacetylase from Xenopus.haevis cofractionates with an associated Snf2 superfamily ATPase. Curr. Biol. (1998) 8:843–846.
   PubMed Web of Science ®Google Scholar
• •This study was the first to describe the characterisation of the Mi-2 complex that unites an HDAC with a chromatin remodelling ATPase. Subsequently described in [70] and [122].
   Google Scholar
• TONG JK, HASSIG CA, SCHNITZLER GR, KINGSTON RE, SCHREIBER SL: Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature (1998) 395:917–921.
   PubMed Web of Science ®Google Scholar
• URNOV FD, YEE J, SACHS L et al: Targeting of N-Co R and histone deacetylase 3 by the oncoprotein v-ErbAyields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO. (2000) 15:1–17.
   Google Scholar
• LI J, WANG J, WANG J et al.: Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO. j (2000) 19:4342–4350.
   PubMed Web of Science ®Google Scholar
• GUENTHER MG, LANE WS, FISCHLE W, VERDIN E, LAZARMA, SHIEKHATTAR R: A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. (2000) 14:1048–1057.
   PubMed Web of Science ®Google Scholar
• •[71-73] offer a variety of data that describe a functional association between unliganded nuclear hormone receptors, the co-repressor N-CoR, and HDAC3, and thus lead to a revision of earlier models.
   Google Scholar
• BIRD AP, WOLFFE AP: Methylation-induced repression-belts, braces and chromatin. Cell (1999) 99:451–454.
   PubMed Web of Science ®Google Scholar
• ALLAND L, MUHLE R, HOU H, JR. et al.: Role for N-CoRand histone deacetylase in Sin3-mediated transcrip-tional repression [see comments]. Nature (1997) 387:49–55.
   PubMed Web of Science ®Google Scholar
• LUO RX, POSTIGO AA, DEAN DC: Rb interacts withhistone deacetylase to repress transcription. Cell (1998) 92:463–473.
   PubMed Web of Science ®Google Scholar
• LAI A, LEE JM, YANG W-M et al.: RBP1 recruits both histone deacetylase-dep en den t and-in dep en den t repression activities to retinoblastoma family proteins. Mol. Cell. Biol. (1999) 19:6632–6641.
   PubMed Web of Science ®Google Scholar
• HOLSTEGE FC, JENNINGS EG, WYRICK JJ et al.: Dissecting the regulatory circuitry of a eukaryotic genome. Cell (1998) 95:717–728.
   PubMed Web of Science ®Google Scholar
• MOREIRA JM, HOLMBERG S: Transcriptional repression of the yeast CHA1 gene requires the chromatin-remodeling complex RSC. EMBO. (1999)18:2836–2844.
   PubMed Web of Science ®Google Scholar
• •High-quality genetic and structural analysis reveals the unexpected role for chromatin remodelling in effecting targeted repression. Also see [137].
   Google Scholar
• FONDELL JD, BRUNEL F, HISATAKE K, ROEDER RG: Unliganded thyroid hormone receptor a can target TATA-binding protein for transcriptional repression. Mol. Cell. Biol. (1996) 16:281–287.
   PubMedGoogle Scholar
• LEE TI, CAUSTON HC, HOLSTEGE FC et al.: Redundantroles for the TFTID and SAGA complexes in global transcription. Nature (2000) 405:701–704.
   PubMed Web of Science ®Google Scholar
• KUO MH, ZHOU J, JAMBECK P, CHURCHILL ME, ALLIS CD:Llistone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev. (1998) 12:627–639.
   PubMed Web of Science ®Google Scholar
• JOHNSON LM, KAYNE PS, KAHN ES, GRUNSTEIN M: Genetic evidence for an interaction between 5IR3 and histone H4 in the repression of the silent mating loci in Saccharomyces cerevisiae. Proc. Natl. Acad. ScL USA (1990) 87:6286–6290.
   PubMedGoogle Scholar
• SOLOMON MJ, LARSEN PL, VARSHAVSKY A: Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell (1988) 53: 937–947.
   Google Scholar
• ••Pioneering study that describes ChIP methodology, subsequently used with much success (e.g. [58, 59, 85, 86, 88, 89, 154]).
   Google Scholar
• KADOSH D, STRUHL K: Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo. Mol. Cell. Biol. (1998) 18:5121–5127.
   PubMed Web of Science ®Google Scholar
• RUNDLETT SE, CARMEN AA, SUKA N, TURNER BM, GRUNSTEIN M: Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature (1998) 392:831–835.
   PubMed Web of Science ®Google Scholar
• LEE DY, HAYES JJ, PRUSS D, WOLFFE AP: A positive rolefor histone acetylation in transcription factor access to nucleosomal DNA. Cell (1993) 72:73–84.
   PubMed Web of Science ®Google Scholar
• PAREKH BS, MANIATIS T: Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. Mol. Cell. (1999) 3:125–129.
   PubMed Web of Science ®Google Scholar
• CHEN H, LIN RJ, XIE W, WILPITZ D, EVANS RM: Regula-tion of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell (1999) 98:675–686.
   PubMed Web of Science ®Google Scholar
• IMHOF A, YANG XJ, OGRYZKO VV, NAKATANI Y, WOLFFE AP, GE H: Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. (1997) 7:689–692.
   PubMed Web of Science ®Google Scholar
• •This initial observation of non-histone HAT targets was followed by several others, e.g. [89, 91–94].
   Google Scholar
• GU W, ROEDER RG: Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell (1997) 90:595–606.
   PubMed Web of Science ®Google Scholar
• BOYES J, BYFIELD P, NAKATANI Y, OGRYZKO V: Regula-tion of activity of the transcription factor GATA-1 by acetylation. Nature (1998) 396:594–598.
   PubMed Web of Science ®Google Scholar
• ZHANG W, BIEKER JJ: Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Nad Acad. ScL USA (1998) 95:9855–9860.
   PubMed Web of Science ®Google Scholar
• SOUTOGLOU E, KATRAKILI N, TALIANIDIS I: Acetylation regulates transcription factor activity at multiple levels. Mol. Cell. (2000) 5:745–751.
   PubMed Web of Science ®Google Scholar
• THOMAS GH, ELGIN SC: Protein/DNA architecture ofthe DNase I hypersensitive region of the Drosophila hsp26 promoter. EMBO. J. (1988) 7:2191–2201.
   PubMedGoogle Scholar
• SCHILD C, CLARET FX, WAHLI W, WOLFFE AP: A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro. EMBO. J (1993) 12:423–433.
   PubMedGoogle Scholar
• CIRILLO LA, ZARET KS: An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol. (1999) 4:961–969.
   Google Scholar
• NEDOSPASOV S, GEORGIEV G: Non-random cleavage of SV40 DNA in the compact minichromosome and free in solution by micrococcal nuclease. Biochem. Biophys. Res. Commun. (1980) 29:532–539.
   Google Scholar
• WU C: The 5' ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I. Nature (1980) 286:854–860.
   PubMed Web of Science ®Google Scholar
• ELGIN SC: The formation and function of DNase I hypersensitive sites in the process of gene activation. J. Biol. Chem. (1988) 263:19259–19262.
   PubMedGoogle Scholar
• WINSTON F, CARLSON M: Yeast SNF/SWI transcrip-tional activators and the SPT/SIN chromatin connec-tion. Trends Genet. (1992) 8:387–391.
   PubMed Web of Science ®Google Scholar
• CAIRNS BR, KIM YJ, SAYRE MH, LAURENT BC, KORNBERG RD: A multisubunit complex containing the SWI1/ADR6, SWI2/SNF2, SWI3, SNE5 and SNF6 gene products isolated from yeast. Proc. Natl. Acad. ScL USA (1994) 91:1950–1954.
   PubMed Web of Science ®Google Scholar
• COTE J, QUINN J, WORKMAN JL, PETERSON CL: Stimula-tion of GALA derivative binding to nucleosomal DNA by the yeast SWI/SNFcomplex. Science (1994) 265:53–60.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG JA, EMERSON BM: Transcription of chromatin: these are complex times. CUIT. Opil7. Genet. Dev. (1998) 8:165–172.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review with helpful tables; [105] is also recomended.
   Google Scholar
• KINGSTON RE, NARLIKAR GJ: ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. (1999) 13:2339–2352.
   PubMed Web of Science ®Google Scholar
• WOLFFE AP, GUSCHIN D: Chromatin structural features and targets that regulate transcription. J Struct. (2000) 129:102–122.
   Google Scholar
• SUDARSANAM P, WINSTON F: The Swi/Snf family: nucleosome-remodeling complexes and transcrip-tional control. Trends Genet. (2000) 16:345–351.
   PubMed Web of Science ®Google Scholar
• •Very thoughtful review that addresses many puzzling issues in the field.
   Google Scholar
• KWON H, IMBALZANO AN, KHAVARI PA, KINGSTON RE, GREEN MR: Nucleosome disruption and enhancement of activator binding by a human SW1/SNE complex. Nature (1994) 370:477–481.
   PubMed Web of Science ®Google Scholar
• IMBALZANO AN, KWON H, GREEN MR, KINGSTON RE: Facilitated binding of TATA-binding protein to nucleo-somal DNA. Nature (1994) 370:481–485.
   PubMed Web of Science ®Google Scholar
• BOYER LA, SHAO X, EBRIGHT RH, PETERSON CL: Roles of the histone H2A-H2B dimers and the (H3-H4)(2) tetramer in nucleosome remodeling by the SWI-SNF complex. J. Biol. Chem. (2000) 275:11545–11552.
   PubMedGoogle Scholar
• COTE J, PETERSON CL, WORKMAN JL: Perturbation of nucleosome core structure by the SWI/SNF complex persists after its detachment, enhancing subsequent transcription factor binding. Proc. Natl. Acad. ScL USA (1998) 95:4947–4952.
   PubMedGoogle Scholar
• CLARK DJ, FELSENFELD G: Formation of nucleosomes on positively sup ercoiled DNA. EMBO. J. (1991) 10:387–395.
   PubMed Web of Science ®Google Scholar
• WHITEHOUSE I, FLAUS A, CAIRNS BR, WHITE MF, WORKMAN JL, OWEN-HUGHES T: Nucleosome mobili-zation catalysed by the yeast SWI/SNF complex. Nature (1999) 400:784–787.
   PubMed Web of Science ®Google Scholar
• CHERVITZ SA, ARAVIND L, SHERLOCK G et al.: Comparison of the complete protein sets of worm and yeast: or thology and divergence. Science (1998) 282:2022–2028.
   PubMed Web of Science ®Google Scholar
• TSUKIYAMA T, WU C: Purification and properties of an ATP-dependent nucleosome remodeling factor. Cell (1995) 83:1011–1020.
   PubMed Web of Science ®Google Scholar
• TSUKIYAMA T, PALMER J, LANDEL CC, SHILOACH J, WU C: Characterization of the imitation switch subfamily of ATP-dependent chromatin-remodeling factors in Saccharomyces cerevisiae. Genes Dev. (1999) 13:686–697.
   PubMed Web of Science ®Google Scholar
• HAMICHE A, SANDALTZOPOULOS R, GDULA DA, WU C: ATP-dependent histone octamer sliding mediated by the chromatin remodeling complex NURF. Cell (1999) 97:833–842.
   PubMed Web of Science ®Google Scholar
• •Interesting functional property of NURF revealed in high-resolution in vitro analysis. See also [113, 118, 119, 121].
   Google Scholar
• LANGST G, BONTE EJ, CORONA DF, BECKER PB: Nucleo-some movement by CHRAC and ISWI without disrup-tion or trans-displacement of the histone octamer. Cell (1999) 97:843–852.
   PubMed Web of Science ®Google Scholar
• CORONA DF, LANGST G, CLAPIER CR et al.: ISWI is an ATP-dependent nucleosome remodeling factor. Mol Cell. (1999) 3:239–245.
   PubMed Web of Science ®Google Scholar
• WADE PA, GEGONNE A, JONES PL, BALLESTAR E, AUBRY F, WOLFFE AP: Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation [see comments]. Nature Genet. (1999) 23:62–66.
   PubMed Web of Science ®Google Scholar
• GUSCHIN D, WADE PA, KIKYO N, WOLFFE AP: ATP-Dependent histone octamer mobilization and histone deacetylation mediated by the Mi-2 chromatin remodeling complex. Biochemistry (2000) 39:5238–5245.
   PubMedGoogle Scholar
• ZHANG Y, LEROY G, SEELIG HP, LANE WS, REINBERG D: The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacety-lase and nucleosome remodeling activities. Cell (1998) 95:279–289.
   PubMed Web of Science ®Google Scholar
• ROBERTSON KD, AIT-SI-ALI S, YOKOCHI T, WADE PA, JONES PL, WOLFFE AP: DNNIT1 forms a complex with rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nature Genet. (2000) 25:338–342.
   PubMed Web of Science ®Google Scholar
• •A biochemical and functional association between DNMT1, Rb, E2F and HDAC1.
   Google Scholar
• ZHANG Y, IRATNI R, ERDJUMENT-BROMAGE H, TEMPST P, REINBERG D: Ilistone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell (1997) 89:357–364.
   PubMedGoogle Scholar
• OGRYZKO W, KOTANI T, ZHANG X et al.: Ilistone-like TAFs within the PCAF histone acetylase complex [see comments]. Cell (1998) 94:35–44.
   PubMedGoogle Scholar
• VASSILEV A, YAMAUCHI J, KOTANI T et al.: The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol. Cell. (1998) 2:869–875.
   PubMedGoogle Scholar
• IKURA T, OGRYZKO VV, GRIGORIEV M et al.: Involve-ment of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell (2000) 102:463–473.
   PubMed Web of Science ®Google Scholar
• WANG W, XUE Y, ZHOU S, KUO A, CAIRNS BR, CRABTREE GR: Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. (1996) 10:2117–2130.
   PubMed Web of Science ®Google Scholar
• WANG W, COTE J, XUE Y et al.: Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO. J. (1996) 15:5370–5382.
   PubMed Web of Science ®Google Scholar
• PHELAN ML, SIF S, NARLIKAR GJ, KINGSTON RE: Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol. Cell. (1999) 3:247–253.
   PubMed Web of Science ®Google Scholar
• GUSCHIN D, GEIMAN TM, KIKYO N, TREMETHICK DJ, WOLFFE AP, WADE PA: Multiple ISWI ATPase complexes from Xenopus/aevis: functional conserva-tion of an ACF/CHRAC homolog. J. Biol. Chem. (2000) 10.1074/jbc.M006041200.
   Google Scholar
• POOT RA, DELLAIRE G, HULSMANN BB et al: HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins [in process citation]. EMBO. (2000) 19:3377–3387.
   PubMedGoogle Scholar
• HIRSCHHORN JN, BROWN SA, CLARK CD, WINSTON F: Evidence that SNF2 /SWI2 and SNE5 activate transcrip-tion in yeast by altering chromatin structure. Genes Dev. (1992) 6:2288–2298.
   PubMed Web of Science ®Google Scholar
• •Pioneering analysis that demonstrated a role for histones in SWI/SNF-mediated gene control. See also [134, 135].
   Google Scholar
• KRUGER W, PETERSON CL, SIL A et al.: Amino acid substi-tutions in the structured domains of histones H3 and H4 partially relieve the requirement of the yeast SWI/SNF complex for transcription. Genes Dev. (1995) 9:2770–2779.
   PubMed Web of Science ®Google Scholar
• RECHT J, OSLEY MA: Mutations in both the structured domain and N-terminus of histone H2B bypass the requirement for Swi-Snf in yeast. EMBO. J (1999) 18:229–240.
   PubMedGoogle Scholar
• SUDARSANAM P, IYER VR, BROWN PO, WINSTON F: Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc. Natl. Acad. ScL USA (2000) 97:3364–3369.
   PubMed Web of Science ®Google Scholar
• •Complexity of SWI/SNF action revealed in high-resolution genetic analysis.
   Google Scholar
• GREGORY PD, SCHMID A, ZAVARI M, MUNSTERKOTTER M, HORZ W: Chromatin remodelling at the PHO8 promoter requires SWI-SNF and SAGA at a step subsequent to activator binding. EMBO. J. (1999) 18:6407–6414.
   PubMedGoogle Scholar
• •Combination of genetic and structural analysis illuminates role for SWI/SNF action. See also [154].
   Google Scholar
• PAZIN MJ, BHARGAVA P, GEIDUSCHEK EP, KADONAGA JT: Nucleosome mobility and the maintenance of nucleosome positioning. Science (1997) 276:809–812.
   PubMedGoogle Scholar
• •Elegant experiment illuminates findings in [113, 117, 119, 121].
   Google Scholar
• GROSS DS, GARRARD WT: Nuclease hypersensitive sites in chromatin. Ann. Rev. Biochem. (1988) 57:159–197.
   PubMed Web of Science ®Google Scholar
• FRYER CJ, ARCHER TK: Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature (1998) 393:88–91.
   PubMed Web of Science ®Google Scholar
• KOWENZ-LEUTZ E, LEUTZ A: A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell. (1999) 4:735–743.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG JA, BIEKER JJ, EMERSON BM: A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell (1998) 95:93–104.
   Google Scholar
• LEE CH, MURPHY MR, LEE JS, CHUNG JH: Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells. Proc. Natl. Acad. ScL USA (1999) 96:12311–12315.
   PubMedGoogle Scholar
• ••Genetic evidence for involvement of hSWI/SNF inmalignancy.
   Google Scholar
• ROUSSEAU-MERCK MF, VERSTEEGE I, LEGRAND I et al.: hSNF5/IN11 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res. (1999) 59:3152–3156.
   PubMed Web of Science ®Google Scholar
• VERSTEEGE I, SEVENET N, LANGE J et al.: Truncating mutations of hSNF5/IN11 in aggressive paediatric cancer. Nature (1998) 394:203–206.
   PubMed Web of Science ®Google Scholar
• HU YF, HAO ZL, LI R: Chromatin remodeling and activa-tion of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1. Genes Dev. (1999) 13:637–642.
   PubMed Web of Science ®Google Scholar
• BOCHAR DA, WANG L, BENIYA H et al.: BRCA1 is associ-ated with a human SWI/SNF-related complex: linking chromatin remodelling to breast cancer. Cell (2000) 102:257–265.
   PubMed Web of Science ®Google Scholar
• •Unexpected co-purification of BRCA1 and hSWI/SNF. See also [194].
   Google Scholar
• DEURING R, FANTI L, ARMSTRONG JA et al.: The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in viva Mol Cell. (2000) 5:355–365.
   Google Scholar
• TSUKIYAMA T, DANIEL C, TAMKUN J, WU C: ISWI, a member of the SW12/SNE2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell (1995) 83:1021–1026.
   PubMedGoogle Scholar
• KEHLE J, BEUCHLE D, TREUHEIT S et al.: dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science (1998) 282:1897–1900.
   PubMed Web of Science ®Google Scholar
• CH'NG Q, KENYON C: eg1-27 generates anteroposterior patterns of cell fusion in C. elegans by regulating Hox gene expression and Hox protein function. Develop-ment (1999) 126:3303–3312.
   Google Scholar
• HERMAN MA, CH'NG Q, HETTENBACH SM, RATLIFF TM, KENYON C, HERMAN RK: EGL-27 is similar to a metastasis-associated factor and controls cell polarity and cell migration in C. elegans. Development (1999) 126:1055–1064.
   Google Scholar
• ARCHER TK, LEFEBVRE P, WOLFORD RG, HAGER GL: Transcription factor loading on the MMTVpromoter: a bimodal mechanism for promoter activation. Science (1992) 255:1573–1576.
   PubMed Web of Science ®Google Scholar
• COSMA MP, TANAKA T, NASMYTH K: Ordered recruit-ment of transcription and chromatin remodeling factors to a cell cycle-and developmentally regulated promoter. Cell (1999) 97:299–311.
   PubMed Web of Science ®Google Scholar
• ••Superb integration of yeast genetics with high-resolutionChIP analysis offers the most detailed view of the sequence of action transcriptional regulators and chromatin modifica-tion/remodelling machines at any eukaryotic promoter to date. See also [155].
   Google Scholar
• KREBS JE, KUO MH, ALLIS CD, PETERSON CL: Cell cycle-regulated histone acetylation required for expression of the yeast HO gene. Genes Dev. (1999) 13:1412–1421.
   PubMed Web of Science ®Google Scholar
• WONG J, SHI YB, WOLFFE AP: A role for nucleosome assembly in both silencing and activation of the Xenopus TR 13 A gene by the thyroid hormone receptor. Genes Dev. (1995) 9:2696–2711.
   PubMedGoogle Scholar
• LI Q, IMHOF A, COLLINGWOOD TN, URNOV FD, WOLFFE AP: p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption. EMBO. J. (1999) 18:5634–5652.
   PubMedGoogle Scholar
• CIRILLO LA, MCPHERSON CE, BOSSARD P et al.: Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO. J. (1998) 17:244–254.
   PubMed Web of Science ®Google Scholar
• MCPHERSON CE, SHIM EY, FRIEDMAN DS, ZARET KS: An active tissue-specific enhancer and bound transcrip-tion factors existing in a precisely positioned nucleo-somal array. Cell (1993) 75:387–398.
   PubMedGoogle Scholar
• RUBINSTEIN JH: Broad thumb-hallux (Rubinstein-Taybi) syndrome 1957-1988. Am. J. Med. Genet. Suppl. (1990) 6:3–16.
   PubMedGoogle Scholar
• GOODMAN RH, SMOLIK S: CBP/p300 in cell growth, transformation and development. Genes Dev. (2000) 14:1553–1577.
   PubMed Web of Science ®Google Scholar
• OIKE Y, HATA A, MAMIYA T et al.: Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet. (1999) 8:387–396.
   PubMed Web of Science ®Google Scholar
• YAO TP, OH SP, FUCHS M et al.: Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell (1998) 93:361–372.
   PubMed Web of Science ®Google Scholar
• KUNG AL, REBEL VI, BRONSON RT et al.: Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. (2000) 14:272–277.
   PubMed Web of Science ®Google Scholar
• REFETOFF S, WEISS RE, USALA SJ: The syndromes of resistance to thyroid hormone. Endocr. Rev. (1993) 14:348–99.
   PubMed Web of Science ®Google Scholar
• CHATTERJEE VK: Resistance to thyroid hormone. Horm. Res. (1997) 48:43–46.
   PubMed Web of Science ®Google Scholar
• ZHANG J, LAZAR MA: The mechanism of action of thyroid hormones. Ann. Rev Physiol (2000) 62:439–466.
   PubMed Web of Science ®Google Scholar
• JONES PA, LAIRD PW: Cancer epigenetics comes of age. Nature Genet. (1999) 21:163–167.
   PubMed Web of Science ®Google Scholar
• WOLFFE AP, MATZKE MA: Epigenetics: regulation through repression. Science (1999) 286:481–486.
   PubMed Web of Science ®Google Scholar
• JONES PL, VEENSTRA GJ, WADE PA et al.: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. (1998) 19:187–191.
   PubMed Web of Science ®Google Scholar
• •Together with [171], this study illuminated the mechanistic connection between DNA methylation-driven transcrip-tional repression and the targeting of histone deacetylase.
   Google Scholar
• NAN X, NG HH, JOHNSON CA et al.: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 393:386–389.
   PubMed Web of Science ®Google Scholar
• ROBERTSON KD, JONES PA: DNA methylation: past, present and future directions. Carcinogenesis (2000) 21:461–467.
   PubMed Web of Science ®Google Scholar
• SHERR CJ, ROBERTS JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. (1999) 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• RHEE I, JAIR KW, YEN RW et al.: CpG methylation is maintained in human cancer cells lacking DrsIMT1 . Nature (2000) 4 0 4 :1003–1007.
   Google Scholar
• ••The very unexpected lack of an effect of deleting DNMT1 ongenomic methylation levels.
   Google Scholar
• HANSEN RS, WIJMENGA C, LUO P et al.: The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. ScL USA (1999) 96:14412–14417.
   PubMed Web of Science ®Google Scholar
• XU GL, BESTOR TH, BOURC'HIS D et al.: Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature (1999) 402:187–191.
   PubMed Web of Science ®Google Scholar
• ••Mutation in DNMT3b causes human ICF syndrome. See also[175, 177].
   Google Scholar
• BROWN DC, GRACE E, SUMNER AT, EDMUNDS AT, ELLIS PM: ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome. Hum. Genet. (1995) 96:411–416.
   Google Scholar
• WAUGH-O'NEILL RJ, O'NEILL MJ, MARSHALL-GRAVES JA: Undermethylation associated with retroelement activation and chromosome remodelling in an interspecific mammalian hybrid. Nature (1998) 3 93:68–72.
   Google Scholar
• •Elegant proof of genome defence function for DNA methylation.
   Google Scholar
• AMIR RE, VAN DEN VEYVER IB, WAN M, TRAN CQ, FRANCKE U, ZOGHBI HY: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-bindingprotein 2. Nature Genet. (1999) 23:185–188.
   PubMed Web of Science ®Google Scholar
• ••Profound neurological abnormalities caused by MeCP2mutations. See also [180-182].
   Google Scholar
• VAN DEN VEYVER TB, ZOGHBI HY: Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr. Opin. Genet. Dev. (2000) 10:275–279.
   Google Scholar
• BALLESTAR E, YUSUFZAI TM, WOLFFE AP: Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA [in process citation]. Biochemistry (2000) 39:7100–7106.
   PubMed Web of Science ®Google Scholar
• KALUDOV NK, WOLFFE AP: MeCP2 driven transcrip-tional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res. (2000) 28:1921–1928.
   PubMedGoogle Scholar
• UN RJ, EGAN DA, EVANS RM: Molecular genetics of acute promyelocytic leukemia. Trends Genet. (1999) 15:179–184.
   Google Scholar
• DE THE H, CHOMIENNE C, LANOTTE M, DEGOS L, DEJEAN A: The t(15;17) translocation of acute promye-locytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature (1990) 347:558–561.
   PubMed Web of Science ®Google Scholar
• •Mistargeting of HDAC in leukaemia. See also [185–188].
   Google Scholar
• BORROW J, GODDARD AD, SHEER D, SOLOMON E: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science (1990) 249:1577–1580.
   PubMed Web of Science ®Google Scholar
• ALCALAY M, ZANGRILLI D, PANDOLFI PP et al.: Translo-cation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alocus. Proc. Natl. Acad. ScL USA (1991) 88:1977–1981.
   PubMed Web of Science ®Google Scholar
• GRIGNANI F, DE MATTEIS S, NERVI C et al.: Fusion proteins of the retinoic acid receptor-arecruit histone deacetylase in promyelocytic leukaemia. Nature (1998) 391:815–818.
   PubMed Web of Science ®Google Scholar
• UN RJ, NAGY L, INOUE S, SHAO W, MILLER WH, JR., EVANS RM: Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (1998) 391:811–814.
   Google Scholar
• SLACK JL, RUSINIAK ME: Current issues in the manage-ment of acute promyelocytic leukemia. Ann. Hematol. (2000) 79:227–238.
   PubMed Web of Science ®Google Scholar
• ARCHER SY, HODIN RA: Flistone acetylation and cancer. Curr. Opin. Genet. Dev. (1999) 9:171–174.
   PubMed Web of Science ®Google Scholar
• ARCHER SY, MENG S, SHEI A, HODIN RA: p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. ScL USA (1998) 95:6791–6796.
   PubMed Web of Science ®Google Scholar
• DUNAIEF JL, STROBER BE, GUHA S et al.: The r etinoblas-toma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell (1994) 79:119–130.
   Google Scholar
• WARRELL RP, JR., HE LZ, RICHON V, CALLEJA E, PANDOLFI PP: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. (1998) 90:1621–1625.
   PubMed Web of Science ®Google Scholar
• ••First reported use of a HDAC inhibitor in clinical practice.
   Google Scholar
• CAMERON EE, BACHMAN KE, MYOHANEN S, HERMAN JG, BAYLIN SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet. (1999) 21:103–107.
   PubMed Web of Science ®Google Scholar
• ••Complexity of methylation-driven repression pathways asrevealed by various pharmacological regimens.
   Google Scholar
• LUBBERT M: DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr. Top. Microbiol Immunol (2000) 249:135–164.
   PubMed Web of Science ®Google Scholar
• KIM JS, PABO CO: Getting a handhold on DNA: design of poly-zinc finger proteins with femtomolar dissocia-tion constants. Proc. NatL Acad. Sci. USA (1998) 95:2812–2817.
   PubMed Web of Science ®Google Scholar
• BEERLI RR, DREIER B, BARBAS CF, 3RD: Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl. Acad. ScL USA (2000) 97:1495–500.
   PubMed Web of Science ®Google Scholar
• YOUNG RA: Biomedical discovery with DNA arrays. Cell (2000) 102:9–15.
   PubMed Web of Science ®Google Scholar
• RICHON VM, WEBB Y, MERGER R et al.: Second genera-tion hybrid polar compounds are potent inducers of transformed cell differentiation. Proc. Natl. Acad. ScL USA (1996) 93:5705–5708.
   PubMed Web of Science ®Google Scholar